The CellBRx Single use Bioreactors from OmniBRx is the world’s largest and most efficient vaccine manufacturing platform for large scale vaccines and viral vector Production. OmniBRx is also the creator of world's first integrated seed train development platforms in close-loop sequentially programmed bioreactor systems” Ravindra added.

With infusion of series-A funds, OmniBRx is all set to expand their business in the overseas market. The company would also invest in adding to its capacity and build best in class manufacturing facilities to augment its production capabilities and meet growing market demands.

Sajit Kumar. Sr. VP at SIDBI Venture Capital Limited quoted “We are happy to partner with OmniBRx. We believe that their focus and deep domain knowledge will help them to penetrate the global markets.

This is our third investment out of “Ubharte Sitaare Fund”, fund for MSME’s focused on scaling up in the export markets. Wishing them all the best". Delhi based Indus Capital a boutique investment bank, founded by Mr. Santosh Patra was the exclusive financial advisor to OmniBRx for this transaction.